Skip to main content
Log in

Therapie der Hepatitis D

The Hep-Net International Delta Hepatitis Intervention Trial

Therapy of hepatitis delta: The Hep-Net International Delta Hepatitis Intervention Trial

  • Klinische Studien
  • Published:
Der Internist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Campbell F, Smedile A, Manns MP et al (2005) Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study. Aliment Pharmacol Ther 22:227–232

    Article  PubMed  Google Scholar 

  2. Castelnau C, Le Gal F, Ripault MP et al (2006) Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up. Hepatology 44:728–735

    Article  PubMed  CAS  Google Scholar 

  3. Garripoli A, Di Marco V, Cozzolongo R et al (1994) Ribavirin treatment for chronic hepatitis D: a pilot study. Liver 14:154–157

    PubMed  CAS  Google Scholar 

  4. Su CW, Huang YH, Huo TI et al (2006) Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients. Gastroenterology 130:1625–1635

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Nattermann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nattermann, J., Nitschmann, S. Therapie der Hepatitis D. Internist 52, 1365–1366 (2011). https://doi.org/10.1007/s00108-011-2943-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-011-2943-z

Navigation